Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...
Hosted on MSN
Machine learning helps tailor deep brain stimulation to improve gait in Parkinson’s disease
A team of researchers at the University of California, San Francisco has developed a data-driven method for optimizing deep brain stimulation (DBS) settings that significantly improved walking ...
EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results